Anthrax Research Today is a free monthly online journal that collates and summarizes the latest research about Anthrax, including details on bacillus anthracis, contagiousness, exposure, effects.

Volume 3 (2007), Issue 7 (July)

1. Evaluation of immune response to orally administered Sterne strain 34F2 anthrax vaccine.
   Vaccine, 25(29): 5374-7. [Abstract] [Full-text]
2. Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1.
   J Biol Chem, 282(27): 19781-7. [Abstract] [Full-text]
3. A high-throughput screening approach to anthrax lethal factor inhibition.
   Bioorg Chem, 35(4): 306-12. [Abstract] [Full-text]
4. Enzymatic Logic of Anthrax Stealth Siderophore Biosynthesis: AsbA Catalyzes ATP-Dependent Condensation of Citric Acid and Spermidine.
   J Am Chem Soc, 129(27): 8416-7. [Abstract] [Full-text]
5. Colorimetric detection of anthrax DNA with a Peptide nucleic Acid sandwich-hybridization assay.
   J Am Chem Soc, 129(27): 8424-5. [Abstract] [Full-text]
6. Strengthening bioterrorism prevention: global biological materials management.
   Biosecur Bioterror, 5(2): 107-16. [Abstract] [Full-text]
7. Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens.
   J Biol Chem, 282(29): 20847-53. [Abstract] [Full-text]
8. WITHDRAWN: Vaccines for preventing anthrax.
   Cochrane Database Syst Rev. [Abstract] [Full-text]
9. Lethal factor of anthrax toxin binds monomeric form of protective antigen.
   Biochem Biophys Res Commun, 360(3): 690-5. [Abstract] [Full-text]
10. Novel semisynthetic derivative of antibiotic Eremomycin active against drug-resistant gram-positive pathogens including Bacillus anthracis.
    J Med Chem, 50(15): 3681-5. [Abstract] [Full-text]
11. Human lung innate immune response to Bacillus anthracis spore infection.
    Infect Immun, 75(8): 3729-38. [Abstract] [Full-text]
12. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Infect Immun, 75(8): 4020-9. [Abstract] [Full-text]
13. High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation.
    Antimicrob Agents Chemother, 51(8): 2758-64. [Abstract] [Full-text]
14. Immune response to two different dosing schedules of the anthrax vaccine precipitated (AVP) vaccine.
    Vaccine, 25(32): 6089-97. [Abstract] [Full-text]
15. Detection of anti-protective antigen salivary IgG antibodies in recipients of the US licensed anthrax vaccine.
    Vaccine, 25(32): 5978-84. [Abstract] [Full-text]
16. Caspase-1 inflammasomes in infection and inflammation.
    J Leukoc Biol, 82(2): 220-5. [Abstract] [Full-text]
17. Inhibitors of anthrax lethal factor.
    Bioorg Med Chem Lett, 17(16): 4575-8. [Abstract] [Full-text]

© 2005-2008 Anthrax Research Today. All Rights Reserved.